EUPRAXIA PHARMACEUTICALS INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
EUPRAXIA PHARMACEUTICALS INC. (EPRX) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $2.36 million for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-03-13
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|
| 2025-12-31 | $2.36M 40-F · filed 2026-03-13 |
| 2024-12-31 | -$714.88K 40-F · filed 2026-03-13 |
| 2023-12-31 | $577.91K 40-F · filed 2025-03-20 |
| 2022-12-31 | $1.32M 40-F · filed 2024-04-01 |